In contrast, high levels of homogenously distributed EpCAM are detectable on cells of epithelial tumors [15,16], and its overexpression represents an independent prognostic marker for reduced survival in patients with breast and ovarian cancer [17,18]. This evidence concerns the gene EPCAM and ovarian cancer.